Stopping azithromycin mass drug administration for trachoma: A systematic review.
The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years. Azithromycin targets the ocular strains of Chlamydia trachomatis that cause trachoma. Regio...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Public Library of Science (PLoS)
2021-07-01
|
| Serie: | PLoS Neglected Tropical Diseases |
| Accesso online: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009491&type=printable |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|